
European Journal of Medicinal Chemistry p. 227 - 232 (1989)
Update date:2022-08-06
Topics:
Anagnostopulos, Hiristo
Bartlett, Robert R.
Elben, Ulrich
Stoll, Paul
A series of pyridines were synthesized and evaluated as bronchospasmolytic / anti-allergic agents.Several of these compounds were found to: 1) inhibit the release of histamine; 2) antagonize histamine, bradykinin, LTD4 and PAF; 3) suppress the IgE-mediated passive cutaneous anaphylaxis (PCA) reaction.The most interesting substance of this series 2,6-dimethyl-3-nitro-4<(2-(4-diphenylmethyl-1-piperazinyl)ethyl)amino>pyridine 1, (HWA 214), was selected for further pharmacological evaluation.The novel, orally active agent 1 does not have such drawbacks as causing drowsiness or being effective only as a prophylactic drug, and could provide advantages over other non-sedative compounds, such as terfenadine and astemizole, in that it is water soluble and thus can be administered through inhalation or through intravenous application.Keywords: pyridines / H1-antagonistic activity / antiallergic property / antiasthmatic property
View MoreTianjin Tensing Fine Chemical Research Develop Centre
Contact:86-022-23718576,13032267585
Address:2-2-201,13 Guiyuan road,Huayuan Industry district,Tianjin,china
Shandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
Antaeus Bio-technology Co., LTD(expird)
Contact:021-31252569
Address:shanghai pudong
Zhejiang Newfine Industry Co.,Ltd.
Contact:+86-573-82262042
Address:No.225,Dongqing Road, garoms@163.com
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
Doi:10.1016/j.bmcl.2010.09.021
(2010)Doi:10.1021/ja00014a025
(1991)Doi:10.1002/anie.201003172
(2010)Doi:10.1039/c0cc02502j
(2010)Doi:10.1016/j.ejmech.2017.06.012
(2017)Doi:10.1039/c0ob00194e
(2010)